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It  has  been  established  that  aureomycin has  an  inhibitory effect on  the 
multiplication  of  the  agents  of  the  psittacosis-lymphogranuloma  group.  In 
experimental  infection of  laboratory  animals  and  embryonated hens'  eggs, 
this drug has been shown to suppress, but not completely inhibit, the multipli- 
cation of the viruses and to extend the survival time of the infected host (1, 
2). Reports also indicate that it is of some therapeutic value in relieving clini- 
cal symptoms in human infections caused by these agents (3, 4). 
A  study of the growth cycle of meningopneumonitis virus in the allantoic 
cavity of the fertile hen's egg, reported elsewhere (5), strongly suggests that 
the pattern of multiplication of this agent is similar to that described for other 
viruses; i.e., an early period of virus adsorption followed by a  change into a 
non-infectious stage  and a  subsequent  appearance of the new generation of 
virus. If the type of growth of this agent resembles that of true viruses, the 
question arises as to why this agent is susceptible to the action of antibiotics 
which have no effect on other viruses. 
At  present  relatively little  is  known  concerning  the  mechanism  through 
which aureomycin inhibits the growth of the virus. Most of the work on this 
problem has dealt with the final increment of virus. It was the object of the 
present experiments to determine any possible effect which aureomycin might 
have  on  a  particular  phase  of  the  growth  pattern  of  meningopneumonitis 
virus in the chick embryo. It was felt that correlation of an observable effect 
with a  specific phase of growth would be an aid in elucidating the mode of 
action of the drug on this agent. 
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Methods and Materials 
Virus.--The  virus used throughout these studies was the California 10 strain of meningo- 
pneumonitis (MP)  which has been adapted  to  the  allantoic cavity  of  the chick embryo. 
Freshly harvested allantoic fluid of the 10th egg passage of the virus was used in all experi- 
ments. 
Developmental Cyde.--The  pattern of growth of MP virus in the presence of aureomycin 
was studied in the ailantoic membranes of 8 1/~ day fertile hens' eggs. To each embryo which 
had been infected with 0.2 ml. of the appropriate virus dilution by the allantoic route was 
given 1 nag. of aureomycin by the same route and at the times indicated in the various ex- 
periments. Eggs were incubated at 35°C. At the time intervals indicated the allantoic mem- 
branes from three living embryos were harvested. These membranes were pooled and washed 
6 to 7 times in a broth-buffered water mixture (0.02 molar phosphate buffer). Depending upon 
the experiment, the washed membranes were (a) cut up and put in tissue culture or (b) ground 
in a  mortar with sterile alundum to prepare a  20 to 40 per cent suspension for direct infec- 
tivity titration. 
Titrations in M/~e.--Serial tenfold dilutions were made from the ground preparation to 
be studied. Albino Swiss mice of the NII-I strain weighing 12 to 15 gm. were inoculated with 
0.03 ml. of the various dilutions. Five mice were used per dilution. The criterion for infec- 
tivity was death; the 50 per cent end-point (LD60) was calculated by the method of Reed 
and Muench (6). 
Titragons in Eggs.--Serial tenfold dilutions were made from the ground preparation to 
be studied. The various dilutions were inoculated in 0.2 ml. amounts into the allantoic cavity 
of 8 ~  day chick embryos. Six eggs were used per dilution. After 6 days' incubation at 36°C., 
smears were prepared from the allantoic fluid of each living egg and allowed to dry overnight. 
These were stained by the Macchiavello method; the criterion for infectivity was the presence 
of elementary bodies. The 50 per cent end-point (IDs0) was calculated by the method of Reed 
and Muench. 
Tissue Culture Preparation.--Each membrane of a washed pool was cut into 5 or 6 pieces 
and placed in a  sterile 250 ml. flask containing 50 to  60 ml.  of Simms's ultrafiltrate. The 
flasks were stoppered with cotton and sealed by putting parafilm (grade M) tightly over the 
plugs. After the designated incubation time at 36°C., the pieces of tissue were removed from 
the flasks with a large bore pipette. They were then washed and ground in a mortar in prepa- 
ration for infectivity titration. 
Aureornycin.x--Three different lots of the drug were employed: lot No. 4691-165A which 
contained a glycinate buffer; lot No. 4423-1005  which was unbuffered crystals; lot No. 4423- 
10055 which was also unbuffered. The drug was stored in the refrigerator. In preparation for 
use,  it was dissolved in sterile distilled water.  It was injected in 0.2  ml.  quantities in the 
allantoic cavity  unless  otherwise  indicated. 
Analysis of Methods 
Toxicity of Aureomydn.--Based  on mortality determinations, chick embryos appeared to 
tolerate 1 rag. of the drug when injected into the allantoic cavity; this was the quantity used 
in most experiments. In the mouse brain, 0.I mg. of drug in the 0.03 mt. inoculum produced 
no deaths. The preparations used in these experiments carried an amount of drug which was 
well below this level. 
Behavior of Aureomycin in Tissue Culture.--Three observations were made on the fate of 
aureomycin in cultures consisting of minced ailantoic membrane in Simms's fluid :-- 
x This drug was generously supplied by Lederle Laboratories Division, American Cyan- 
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(a) There was no appreciable destruction  of the drug in Simms's fluid over a period of 
25 hours at 36°C. 
(b) A small quantity of aureomycin was found to leave the membranes obtained from 
pretreated  embryos and could be demonstrated in the culture fluid. 
(c) Aureomycin added directly to Simms's fluid containing minced membranes from un- 
treated  embryos became associated in significant amounts with these membranes. The drug 
appeared to enter into the tissue following contact in vitro. 
Washing of Allanto@ Membranes.--It was necessary to determine the amount of washing 
which would remove the excess amount of aureomycin adhering to the membranes following 
introduction of the drug into the atlantoic cavity. Assays were carried out on the consecutive 
wash fluids (broth-buffered water mixture) by the method of Dombush and Pelcak (7). It 
was found that following 5 or 6 washings, the wash fluids contained no demonstrable aureo- 
mycin. 
Effect of "Carried Over" Aureomycin on Titration of Infextivity.--Virus suspended in a 
menstruum containing 1 nag. of drug yielded on intracerebral inoculation of mice a titer that 
differed from the control titer by only 0.7 log or less. In view of this, one may assume that 
even the maximum amount of aureomycin that could possibly be carried over in a treated 
tissue would have no significant effect on titration. 
Persistence of Aureomycin in the Chick Embryo.--Following  inoculation of 1 nag. of aureo- 
mycin, the amount of drug in allantoic fluid decreased from about 150 qt/ml, in the first few 
minutes to 7 "y/ml. at 120 hours. The corresponding change in the allantoic membranes was 
from about 5 "}'/ml. to about 1 "},/ml. However, the figures for the membranes are not exact, 
inasmuch as the assays were done on extracts and the total concentration of the drug in the 
membrane could not be determined. The drug was present in the blood stream, but its con- 
centration varied from experiment to  experiment and none was found 6 to 8 hours after 
treatment. Small amounts of aureomycin were detected  in the liver. Aureomycin was not 
demonstrated in the brain or heart harvested at various intervals (8). 
EXPERTMENTAL 
Failure of Aure~mydn to Affect  "Inert"  Virus.--Two types of experiments 
were designed. In one, aureomycin in several concentrations up to 1 rag. was 
mixed with serial tenfold dilutions of virus in normal allantoi¢ fluid and allowed 
to remain at room temperature for 30 minutes and at 4°C. for  150 minutes. 
Thereafter,  the mixtures were inoculated into chick embryos. 
In  the  other  experiment,  1  rag.  of  drug  was  added  to  MP  virus diluted 
1:5 and 1:1000 in distilled water.  Following incubation at room temperature 
for 30 minutes and at 4°C. for 120 minutes, the preparations were centrifuged 
at 13,000 R.~.~. for  1 hour and the sediments were washed once by a  second 
centrifugation at  this  speed.  The  sediments resuspended  in  distilled water 
were  titrated in mice.  In both experiments, there were no significant differ- 
ences between the treated preparations and control preparations. Thus, aureo- 
mycin had no effect on the extracellular virus particle per se. 
Rdationship of Time of Administration of Drug to  Virus Growth.--The lack 
of effect on inert virus suggested that the drug exerts its effect during the proc- 
ess of viral replication. In studying the effect of aureomycin on viral synthesis, 
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process of multiplication which was most sensitive to the action of the drug. 
This problem was approached in two different ways, by in ovo and tissue cul- 
ture  experiments. 
(a)  In Ovo Studies.--A group of chick embryos were infected with a 10  -9 dilution of virus 
by the allantoic route; at various times after infection, groups of 5 eggs received 1 rag. of 
aureomycin also by the allantoic route. At 30 to 31 hours after infection, when the first in- 
fectious cycle presumably had been completed (5), three membranes from each series of eggs 
were harvested  and titrated  in mice. 
In Fig.  i, it can be seen that regardless of the time at which  aureomycin 
was given,  the amount of infectious virus present at 31  hours  in  the  mem- 
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Fzo. 1. The effect of aureomycin given at various time intervals on the first cycle of virus 
growth in ovo. The titer indicated at 30 hours was that of the controls which received no 
aureomycin. 
branes of treated eggs was less than  that  of the untreated  controls  (except 
possibly the 27 hour preparation in the series employing 10  -~ virus). The most 
pronounced difference in titers was seen when the drug was given during the 
first 8 hours after infection, but it continued to be significant  even when the 
drug was administered  11  hours after infection. 
It does not seem plausible that the observed results could  be explained by 
inhibition of adsorption, for the effect could be achieved beyond the period of 
primary adsorption (9). The more reasonable explanation is that the drug was 
capable of inhibiting some other phase of virus multiplication. 
Titrations in eggs had been found to be a  more sensitive measure  of infec- 
tivity than titrations in  mice (5),  the difference being in the order  of I  to 2 
logs. Therefore, in an attempt to determine  whether small amounts of virus 
(which may have escaped detection by the  mouse method)  developed by 31 
hours when aureomycin was administered  during the early hours of infection, E. G. ALLEN,  A. J. GIRARDI,  M. M. SIGEL,  AND  M. KLEIN  787 
the same experiment was set up employing embryos for titration. For compari- 
son, determinations were carried out at 30, 50, and 72 hours after infection. 
As shown in Table I, results of titrations performed  in eggs were less clear 
cut  than  results of those performed in mice. Reasons for this have been dis- 
cussed previously (5). However,  two facts emerge from this table: (1) Delay 
in the time of administration of aureomycin after infection seemed  to allow 
for  the  appearance of more virus regardless of the  incubation  time.  This  is 
consistent with  the data  obtained  in  the  mouse  experiments.  (2)  Prolonged 
incubation of the infected embryos treated with aureomycin seemed to cause 
TABLE I 
Log Titers (ID6o) in the Membrane When Treated with Drug at Different Times 
Time of titration (after infection 
Time of inoculation  30 hrs.  50 hrs.  72 hrs. 
of aureomycin 
-- 10 rain. 
+1 hr. 
2 hrs. 
4 " 
.5 " 
6 " 
7 " 
8 " 
12 " 
27 " 
28 " 
Control ......... 
Experl-  Experiment I  ment 2 
Negative  I  0.5 
Undiluted 
<2.0 
3.0 
4.5 
5.6 
1.2 
0.4 
<1.0 
4.2 
4.6 
Experiment 1 
Negative 
2.2 
3.0 
3.5 
6.2 
Exp 
me[ 
1. 
2. 
4. 
4. 
4.8 
6.0 
i  2.  Experi- 
ment I 
<1.0 
4.0 
4.7 
5.3 
7.5 
Experi- 
ment 2 
0.6 
3.0 
4.5 
3.4 
6.4 
the appearance of more virus regardless of the time of injection of the drug, 
with the possible exception of the -  10 minute interval. 
(b)  Tissue Culture Studies.--The  second approach to these experiments  was to treat in- 
fected eggs (10  -2 inoculum) with 1 rag. of aureomycin as in (a) but then to remove the mem- 
branes after 2 hours from the environment  of both virus and drug in o~o and place them in 
tissue culture according to the technique  described. 45 to 48 hours after infection the mem- 
branes were harvested from tissue culture and titrated in mice. 
The  results  summarized  in  Fig.  2  show  that  when  aureomycin was  given 
at any time within the first 15 hours of infection, it was able, within 2  hours 
after inoculation into the egg, to become associated with  the allantoic mem- 
brane in such a  way as to inhibit virus growth in tissue  culture. Because the 
same results were obtained with membranes treated as late as  15 hours (several 
hours after completion of primary adsorption) as  with those treated as early 788  PSITTACOSIS-LYM~HOGRANULOM.A  GROUP. III 
as 10 minutes, it would appear that inhibition of adsorption of the virus particle 
to the host cells plays at most a minor role in the mode of action of aureomycin. 
It seems  that virus already adsorbed  becomes  in some manner "inactive" 
for this 48 hour growth period when exposed to the drug. 
Additional experiments  bearing  on this point  were designed.  An attempt 
was made to obtain uniform virus populations as regards stage of development 
at given time intervals by interrupting adsorption at 1 hour. 
A  series of eggs were inoculated with 0.5 ml.  10  -z virus dilution in the atlantoic cavity. 
After a  1 hour adsorption period, the allantoic membranes were harvested, washed, and put 
in tissue culture. At various times after the tissue cultures were set up, 1 mg. of aureomycin 
was added to them. These were harvested after 45 to 48 hours and titrated in mice. 
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FIG. 2. The effect of aureomycin given at various time intervals during first cycle of virus 
growth--infection and treatment in ovo followed by transfer to tissue culture. 
The results of such an experiment were comparable to those found in Fig. 2. 
When drug was added to the tissue  culture at times corresponding  to 2, 4, 
and 8 hours after infection of the egg, little or no virus developed during the 
48 hour growth period.  When drug was added 15  hours after infection,  1.2 
logs of virus was found, and when it was added 24 hours after infection,  2.8 
logs of virus was found. (These figures are averages of duplicate tissue cultures.) 
Thus, the experiment  indicates that the appearance  of increased amount of 
virus with delay in time of administration of the drug could not be explained 
by continued virus adsorption since membranes were removed from the pres- 
ence of virus 1 hour after infection. The results are consistent with previous 
observations  that maximum inhibition of multiplication required administra- 
tion of aureomycin during  the early phases  of virus growth.  Furthermore, 
this experiment offers additional evidence that aureomycin can be absorbed 
in vitro  by the membrane to inhibit virus replication. E.  O. ALLEN,  A.  J.  GIEAI~I,  M.  M.  SIOEL,  AND  M.  KLEIN  789 
It occurred to us that the progressive decrease in the effectiveness of aureo- 
mycin with time was due to its inability to affect virus which had passed a 
certain stage in development. Although final evidence in support of this hy- 
pothesis is not available at this time, a preliminary experiment suggested this 
to be true. In this experiment, aureomycin did not seem to affect infectious 
virus present in membranes in the later hours of the first cycle. 
The data obtained in the tissue culture experiments and in ovo studies con- 
cerning the relationship of the time of administration of the drug to its effect 
on virus yield suggested that the maximum effect could be achieved only if 
aureomycin were given early but  that  the drug seemed to affect some step 
following adsorption. In order to test this hypothesis an experiment was de- 
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I~G. &The effect of aureomycin given at the time of ;nfec~on  on the  growth pattern of 
MP virus in the allantoic membrane of the chick embryo. 
signed in which a  comparison was made of the growth curve of MP virus in 
treated and untreated embryos. 
The Effect of Aureomycin  on  Virus  Growth in Allantoic Membranes--Effect 
on Growth Curve.--It can be seen in Fig. 3 that when aureomycin was given at 
the time of infection, the most pronounced effect of the drug on the growth 
pattern seemed to be the extension of the "latent" period. There were noted 
some  slight  differences in  the  titers  of  treated  and  untreated  membranes 
during the early hours. Even if these differences were attributed to a difference 
in the amount of virus adsorbed, they would not be sufficiently large to account 
for the prolonged latent phase. This fact seems to be an indication of a complex 
action of the drug, within the membrane, which inhibits the completion of the 
growth cycle. 
The degree to which the "latent" period was extended by the presence of 
aureomycin seemed to be related  to the amount of virus inoculated. When 790  PSITTACOSIS-LYM:PHOGRANULOMA  GROUP.  III 
10  -1 inoculum was used, an increase in virus was first noted at 50 hours; when 
10  --2 dilution of inoculum was employed, the increase of virus in the membranes 
did not occur until about 120 hours (sometimes 96 hours) after infection. Thus, 
the time of appearance of new infectious virus was significantly different from 
that of 22 to 24 hours which was the case in the control membranes. 
It would seem that as the concentration of aureomycin decreases, a  certain 
critical level is reached which  cannot  keep virus in  the non-infectious phase 
and thus  the virus goes on to complete its cycle of multiplication.  This pos- 
sibility was tested by again injecting  the eggs with  1 mg. of aureomycin at 
72 hours after infection. It can be seen in Fig. 3 that this procedure caused a 
further delay in the appearance of new virus beyond 144 hours. 
TABLE II 
The Time of Appearance of New Virus in Treated Membranes in Tissue Culture 
T/me preparation  of tissue culture  Time in tissue culture  Total growth time 
(hrs. of growth  in ovo)*  at titration  at titration  Log titer in mice (LDw) 
7 
7 
7A~ 
72 
Ills° 
41 
65 
65 
72 
~lr$. 
48 
72 
72 
144 
Negative 
3.4 
Negative 
3.2 
* Eggs inoculated with 10-~ virus q- 1 mg. drug at 0 hour. 
1 mg. aureomycin added to tissue culture also. 
Difference in the  Time of Appearance  of New  Virus in  Treated Membranes 
in  Tissue Culture and in Ovo.--It has been noticed  that membranes of eggs 
which had been inoculated with 10  -2 dilution of virus and 1 mg. of aureomycin 
simultaneously,  then  transferred  to  tissue  culture  during  the  early hours of 
infection, developed a  small amount of virus (approximately 0.5  log) after a 
48 hour growth period. This was not found at corresponding times in growth 
cycle experiments (also using 10  --2 dilution of virus) when direct titration of the 
membranes  was  made.  Furthermore,  as  shown  in  Table  II,  membranes,  if 
allowed to remain in tissue culture for another 24 hours (a total of 65 hours 
in tissue culture), yielded significant virus titers. 
This suggested that the critical concentration of aureomycin in tissue culture 
may have been reached within 65 hours after the membranes were placed in 
tissue culture. It has already been mentioned that part of the aureomycin sepa- 
rates from the allantoic membranes in tissue culture. This would aid in reaching 
the critical low level of drug earlier than in the treated egg. 
When  1 rag.  of aureomycin was added  to  treated  infected membranes in 
tissue culture (preparation 7A in Table II), the "latent" period was extended 
beyond the  72  hour period. F..  G.  ALLEN,  A.  ~.  GIRARDI,  M.  M.  SIGEL~  AND  M.  KLEIN  791 
The reason for the effect of the addition of drug to the tissue culture was not 
determined. It may have been (a) that an additional amount of drug was taken 
into the membrane from the tissue culture fluid, or (b) that an equilibrium was 
established which prevented further "leakage" of the drug from the membrane. 
It was shown previously that aureomycin in Simms's fluid was able to become 
associated with  the  membrane. 
It was evident from these experiments that the same virus material which 
was in some manner "kept" in the non-infectious phase by the action of aureo- 
mycin  (48  hour  tissue  culture  titration)  was  able  to  complete the  cycle  of 
multiplication after the concentration of the drug associated with the mem- 
brane was no longer sufficient to exert its effect (72 hour titration of identical 
tissue cultures). 
Further Evidence for the Intracellular Effect of Aureomycin.--The data show- 
ing that  aureomycin can affect virus after adsorption  to the aliantoic mem- 
brane (Fig.  2) and those showing the extension of the "latent" period in the 
growth cycle (Fig. 3), as well as those illustrating the lack of in vitro effect on 
the virus particle,  suggest  that  the  inhibiting  effect of the drug  was  chiefly 
at the intracellular phase.  Further experiments also lend supporting evidence 
to this hypothesis. 
Normal chick embryos were injected with  1 rag. of aureomycin by the allantoic route. 
The membranes were removed from some of the embryos at 15 minutes and the remainder 
after 2 1/6 hours from the time of administration of the drug. Mter washing in a broth-buffered 
water mixture, these membranes were placed in tissue culture (3 membranes per 50  ml. of 
Simms) and seeded with 2.5 ml. of the appropriate  virus dilution. Control cultures of un- 
treated  membranes and virus were also set up. Mter a growth period of approximately 45 
hours, the membranes were harvested, ground in a mortar, and titrated  in mice. 
The membranes exposed in ovo to 1 rag. of the drug for 2 ~  hours and seeded 
with  10  -1 dilution of virus in tissue culture showed a  1 log difference in titer 
from that of the control (Table III). The membranes which had the same time 
of exposure to the drug but seeded with 10  ~  dilution of virus exhibited a more 
striking difference in  titer when compared with  the  controls.  Thus,  in  these 
experiments there was an inverse relation between the amount of virus inoculum 
and the degree of inhibition of growth. Exposure of the membranes to the drug 
for a  15 minute period did not result in an inhibition of virus growth. In an 
experiment not  reported  in  this paper in  which  aureomycin and  virus were 
administered simultaneously, and the membranes were removed from the eggs 
at  different  intervals  thereafter  to be placed in  tissue culture,  it was found 
that 10 minutes was insufficient for "binding" of aureomycin to the membrane 
(no suppression of viral growth).  An interval of 25  minutes was adequate. 
Further  evidence  pointing  to  the  intracellular  action  of  aureomycin  was 
obtained  by  putting  virus  on  the  ectodermal  layer  of  the  chorioallantoic 
membrane and the drug inside the allantoic cavity. When membranes of these 792  PSITTACOSIS-LYMPHOGRANULOMA  GROUP.  HI 
eggs were put in tissue culture, the resulting titers after 45 to 48 hour growth 
were similar to those presented in Fig. 2. 
Presence of Virus in Various Tissues of the Chick Embryo .--It was mentioned 
earlier in this paper that aureomycin prolongs the survival time of the host 
infected with viruses of the psittacosis-lymphogranuloma group. Furthermore, 
aureomycin is present not only in the allantoic fluids and membranes, but also 
in the bloodstream and in small amounts in the liver. The question which arises 
is whether there might be a relation between the distribution of virus to various 
parts of the embryo and death; survival being the result of prevention of in- 
fection of certain vital organs. 
TABLE III 
Comparison of Amount of Growth in Treated and Unlreated Membranes Seeded with Virus in 
Tissue Culture Log Titers (LD6o) in Mice 
Dilution  Membranes exposed to drug 2~ hrs.  Membranes exposed to drug 15 min. 
of seed 
Control  Treated  Difference  Difference 
10-t 
10-1 
10-~ 
10-s 
3.5 
3.8 
2.6 
1.8 
2.5 
2.8 
0.3 
0.2 
1.0 
1.0 
2.3 
1.6 
Control  Treated 
3.8  3.8  0.0 
In preliminary experiments, liver, brain, plasma, and allantoic membranes 
of drug-treated eggs were titrated in mice to determine the amount of virus 
present. 
In these experiments, 0.2 ml. of 10  -2 dilution of virus inoculum and 1 rag. of aureomycin 
were administered to 10 day eggs simultaneously in the aUantoic cavity. At the time intervals 
indicated, the organs from an average of eight living embryos were harvested, ground, and 
titrated. 
The results of such an experiment as seen in Table IV show that in untreated 
eggs in which the titer of the allantoic membrane is increasing after 24 hours, 
virus appeared in both plasma and liver after 48 hours and in the brain  72 
hours after infection. In the case of the treated embryos in which the titer of 
the membrane does not begin to rise until  120 hours after infection, no virus 
could be detected in the liver until 144 hours. As late as 192 hours after infec- 
tion, no virus could be found in the brain tissue of treated embryos. Neither, 
however, was aureomycin found on assay of brain material. The above results 
were found in three separate experiments. However, similar experiments have 
not been done using dead embryos for purposes of comparison. 
In two  experiments there  was an apparent  disappearance of virus at  168 
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cannot be adequately explained. In one experiment, the 192 hour interval was 
also associated with a  low titer. 
At these time intervals, the embryos were 17 or 18 days old and one possible 
explanation might  be  the  development of antibodies  by the  chick embryo. 
TABLE IV 
Presence of Virusin Various Tissues of TreaJedand U~reaSed Embryos Log Titers (LDie) in Mire 
Treated embryos  Untreated embryos 
Time  I 
Liver  Brain  plasma  Membrane  [ Pla~ 
]W$o 
3 
24 
48 
72 
9O 
120 
144 
168 
192 
t  in 
Ne,gative  Negative,, 
0.62  " 
Negative  " 
3.4 
i ! 
<t.o 
<1.o 
<1.0  1 
<1,0  1.5 
Negative 
4.0 
Liver  i.  Brain 
Negative  '  Negative 
0.62  " 
1.5  0.2 
2.1  2.0 
<1.0  I 
<1.o  [ 
2.0[ 
brahe 
3.5 
4.5 
5.8 
DISCUSSION 
In an attempt to determine the action which aureomycin exerts on the growth 
of a virus, it was necessary to consider the effect of the drug on extracellular 
virus, on adsorption of virus to host tissue, and on intracellular growth of the 
virus. The findings indicated that the drug had no in dtro effect on the  MP 
virus particle itself; that is, aureomycin was not  capable of altering the extra- 
cellular virus. Wong and  Cox  (2) previously had shown that  this antibiotic 
had an in viva rather than an in vilro effect on viruses of this group. In the 
experiments herein described, no significant effect of the  drug on adsorption 
of the virus to host tissue seemed to be apparent. It is possible that there existed 
some  slight  differences in virus adsorption on  treated and  untreated  mem- 
branes. 
Aureomycin became associated with the host  tissue. The fact that the drug 
was found in the bloodstream of the embryo early was suggestive that it was 
taken  in  the  circulatory system and  thence  to  the  tissues.  However, other 
experiments indicated that the in vitro exposure of normal allantoic membranes 
to aureomycin led to its association with the tissue and the suppression of virus 
growth. Therefore, it would appear that aureomycin may enter the membrane 
directly from the  allantoic fluid  as well as  through  the  circulatory system. 
Regardless of the route by which the  drug reached the cells,  it seems that its 
prime action was on the virus-host complex, as evidenced by the extension of 
the  "latent" period. 794  PSITTACOSI$-LYMI~HOGRANULO~CA  GROUP.  III 
It was shown that aureomycin in amounts greater than I rag. was toxic and 
produced death in the chick embryo. It is possible that 1 mg. of the drug may 
alter the embryo's metabolism at some critical point essential for virus prolifera- 
tion without producing obviously detectable damage to the host cells. 
In experiments reported here, no direct microscopic examinations were made 
of the drug-treated tissue to determine whether the cells continued to multiply. 
However, comparisons of the rate of growth of allantolc membranes of treated 
and untreated eggs were carried out by marking the position of the membrane 
on the shell each day. There were no significant  differences. 
In our experiments it was found that complete inhibition of multiplication 
during  the time interval  corresponding  to the first cycle of growth occurred 
only if aureomycin was administered during the first 6 to 8 hours.  This would 
seem to indicate that after this time, vires  synthesis had passed beyond the 
process or stage in development which could be blocked by the drug. 
The nature of that part of the mechanism of virus production which is sus- 
ceptible to aureomycin is not known. It could conceivably be protein synthesis. 
Cohen (10) has shown that protein formation is the earliest observable synthetic 
process during  the latent  period of  multiplication  of phage.  A  considerable 
amount of protein is found by the time synthesis of  DNA commences.  Our 
conjecture is in line with the recent observation of Gale (ll)  that aureomycin 
markedly inhibits protein synthesis. These considerations are speculative and 
the  question  of  the nature  of  the  intracellular  action  of aureomycin must 
await further experimentation. 
Results obtained by other workers have indicated other substances  which 
when given before a  critical time in  viral synthesis  were able to inhibit  the 
growth of a particular virus. Ginsberg and Horsfall (12) showed that capsular 
polysaccharide of Friedl~inder  bacillus produced inhibition  of the  growth of 
PVM if given within the first ~¢~ of the latent period of virus growth. Henle 
et al.  (13) found that  multiplication of influenza  virus could be inhibited by 
the injection of homologous irradiated virus after the infection was in progress, 
thus suggesting  that the irradiated virus might still enter the cell and interfere 
with some stage of the development of active virus. Using T, and T~ bacterio- 
phage, Foster (14) showed growth inhibition by adding proflavine during the 
first half of the latent period. Similar work has been done by Cohen and Fowler 
(15) who found that 5-methyltryptophane was capable of inhibiting T~ mul- 
tiplication also if given within the first half of the latent period. 
In  our studies,  no attempt  was made to confirm  the findings  of  Gogolak 
and Weiss (16) that aureomycin causes a change in the morphology of certain 
developmental forms. 
SUMMARY 
The findings  presented  indicate that  aureomycin could become associated 
with tissue of the chick embryo by both hematogenous distribution and direct 
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Treatment of chick embryos infected with MP virus with 1 mg. of aureomy- 
cin by the allantoic route caused an inhibition of virus growth  in the allantoic 
membrane. 
The drug had no effect on "inert" virus, and appeared to have  little effect 
on adsorption of virus to host tissue. 
Complete inhibition  of growth  during  the  time interval corresponding to 
the first cycle of multiplication could be achieved only if the drug was adminis- 
tered within 6 to 8 hours after virus inoculation. 
Partial inhibition of virus multiplication could be achieved even ff the ad- 
ministration was delayed as late as 24 hours after infection. 
In these experiments the chief role of the antibiotic appeared to be one of 
virustasis reflected in a prolongation of the latent period (non-infectious phase). 
The virus was able to resume its growth when a  critical low level of the  drug 
in the allantoic membrane was reached. 
When  infectivity titrations were carried out using various tissues  and or- 
gans of treated and untreated embryos, it was found that  no virus was de- 
tectable in the brains of treated embryos as late as 192 hours after inoculation 
of virus. This was in contrast with the findings in allantoic membranes and 
livers of such embryos; these organs showed virus at  120 and  144 hours, re- 
spectively. In untreated controls, virus appeared in membranes at 24 hours, 
in the liver at 48 hours, and in the brain at 72 hours. 
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